<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34475430</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>02</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Protein disulphide isomerase (PDI) is protective against amyotrophic lateral sclerosis (ALS)-related mutant Fused in Sarcoma (FUS) in in vitro models.</ArticleTitle><Pagination><StartPage>17557</StartPage><MedlinePgn>17557</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">17557</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-96181-2</ELocationID><Abstract><AbstractText>Mutations in Fused in Sarcoma (FUS) are present in familial and sporadic cases of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). FUS is localised in the nucleus where it has important functions in DNA repair. However, in ALS/FTD, mutant FUS mislocalises from the nucleus to the cytoplasm where it forms inclusions, a key pathological hallmark of neurodegeneration. Mutant FUS also inhibits protein import into the nucleus, resulting in defects in nucleocytoplasmic transport. Fragmentation of the neuronal Golgi apparatus, induction of endoplasmic reticulum (ER) stress, and inhibition of ER-Golgi trafficking are also associated with mutant FUS misfolding in ALS. Protein disulphide isomerase (PDI) is an ER chaperone previously shown to be protective against misfolding associated with mutant superoxide dismutase 1 (SOD1) and TAR DNA-binding protein-43 (TDP-43) in cellular and zebrafish models. However, a protective role against mutant FUS in ALS has not been previously described. In this study, we demonstrate that PDI is protective against mutant FUS. In neuronal cell line and primary cultures, PDI restores defects in nuclear import, prevents the formation of mutant FUS inclusions, inhibits Golgi fragmentation, ER stress, ER-Golgi transport defects, and apoptosis. These findings imply that PDI is a new therapeutic target in FUS-associated ALS.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Parakh</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Macquarie Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, 2109, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, 3086, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perri</LastName><ForeName>E R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Macquarie Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, 2109, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, 3086, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vidal</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Macquarie Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sultana</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Macquarie Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, 2109, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, 3086, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shadfar</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Macquarie Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Macquarie Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konopka</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Macquarie Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>C J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Physiology, Anatomy and Microbiology, La Trobe University, Melbourne, VIC, 3086, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spencer</LastName><ForeName>D M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, 3086, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atkin</LastName><ForeName>J D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Macquarie Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, 2109, Australia. julie.atkin@mq.edu.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, 3086, Australia. julie.atkin@mq.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.11.2</RegistryNumber><NameOfSubstance UI="D011393">Procollagen-Proline Dioxygenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 5.3.4.1</RegistryNumber><NameOfSubstance UI="C526497">P4HB protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 5.3.4.1</RegistryNumber><NameOfSubstance UI="D019704">Protein Disulfide-Isomerases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059865" MajorTopicYN="Y">Endoplasmic Reticulum Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="N">Models, Theoretical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011393" MajorTopicYN="N">Procollagen-Proline Dioxygenase</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019704" MajorTopicYN="N">Protein Disulfide-Isomerases</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017510" MajorTopicYN="N">Protein Folding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34475430</ArticleId><ArticleId IdType="pmc">PMC8413276</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-96181-2</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-96181-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mackenzie IR, Neumann M. FET proteins in frontotemporal dementia and amyotrophic lateral sclerosis. Brain Res. 2012;1462:40&#x2013;43. doi: 10.1016/j.brainres.2011.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2011.12.010</ArticleId><ArticleId IdType="pubmed">22261247</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii R, et al. The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology. Curr. Biol. 2005;15:587&#x2013;593. doi: 10.1016/j.cub.2005.01.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2005.01.058</ArticleId><ArticleId IdType="pubmed">15797031</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Hegde ML. New mechanisms of DNA repair defects in fused in sarcoma-associated neurodegeneration: Stage set for DNA repair-based therapeutics? J. Exp. Neurosci. 2019;13:1179069519856358&#x2013;1179069519856358. doi: 10.1177/1179069519856358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1179069519856358</ArticleId><ArticleId IdType="pmc">PMC6558540</ArticleId><ArticleId IdType="pubmed">31217692</ArticleId></ArticleIdList></Reference><Reference><Citation>Konopka A, et al. Impaired NHEJ repair in amyotrophic lateral sclerosis is associated with TDP-43 mutations. Mol. Neurodegener. 2020;15:51. doi: 10.1186/s13024-020-00386-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00386-4</ArticleId><ArticleId IdType="pmc">PMC7488163</ArticleId><ArticleId IdType="pubmed">32907630</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski TJ, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan M, Talbot K, Ansorge O. Pathogenesis of FUS-associated ALS and FTD: Insights from rodent models. Acta Neuropathol. Commun. 2016;4:99. doi: 10.1186/s40478-016-0358-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0358-8</ArticleId><ArticleId IdType="pmc">PMC5011941</ArticleId><ArticleId IdType="pubmed">27600654</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe4;umer D, et al. Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations. Neurology. 2010;75:611&#x2013;618. doi: 10.1212/WNL.0b013e3181ed9cde.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181ed9cde</ArticleId><ArticleId IdType="pmc">PMC2931770</ArticleId><ArticleId IdType="pubmed">20668261</ArticleId></ArticleIdList></Reference><Reference><Citation>Merner ND, et al. Exome sequencing identifies FUS mutations as a cause of essential tremor. Am. J. Hum. Genet. 2012;91:313&#x2013;319. doi: 10.1016/j.ajhg.2012.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2012.07.002</ArticleId><ArticleId IdType="pmc">PMC3415547</ArticleId><ArticleId IdType="pubmed">22863194</ArticleId></ArticleIdList></Reference><Reference><Citation>Seelaar H, et al. Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration. J. Neurol. 2010;257:747&#x2013;753. doi: 10.1007/s00415-009-5404-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-5404-z</ArticleId><ArticleId IdType="pmc">PMC2864899</ArticleId><ArticleId IdType="pubmed">19946779</ArticleId></ArticleIdList></Reference><Reference><Citation>Doi H, Koyano S, Suzuki Y, Nukina N, Kuroiwa Y. The RNA-binding protein FUS/TLS is a common aggregate-interacting protein in polyglutamine diseases. Neurosci. Res. 2010;66:131&#x2013;133. doi: 10.1016/j.neures.2009.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2009.10.004</ArticleId><ArticleId IdType="pubmed">19833157</ArticleId></ArticleIdList></Reference><Reference><Citation>Hicks GG, et al. Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nat. Genet. 2000;24:175&#x2013;179. doi: 10.1038/72842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/72842</ArticleId><ArticleId IdType="pubmed">10655065</ArticleId></ArticleIdList></Reference><Reference><Citation>Blair IP, et al. FUS mutations in amyotrophic lateral sclerosis: Clinical, pathological, neurophysiological and genetic analysis. J. Neurol. Neurosurg. Psychiatry. 2010;81:639&#x2013;645. doi: 10.1136/jnnp.2009.194399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.194399</ArticleId><ArticleId IdType="pubmed">19965854</ArticleId></ArticleIdList></Reference><Reference><Citation>An H, et al. ALS-linked FUS mutations confer loss and gain of function in the nucleus by promoting excessive formation of dysfunctional paraspeckles. Acta Neuropathol. Commun. 2019;7:7. doi: 10.1186/s40478-019-0658-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0658-x</ArticleId><ArticleId IdType="pmc">PMC6330737</ArticleId><ArticleId IdType="pubmed">30642400</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H-X, et al. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann. Neurol. 2010;67:739&#x2013;748. doi: 10.1002/ana.22051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22051</ArticleId><ArticleId IdType="pmc">PMC4376270</ArticleId><ArticleId IdType="pubmed">20517935</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikenaka K, et al. Characteristic features of FUS inclusions in spinal motor neurons of sporadic amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2020;79:370&#x2013;377. doi: 10.1093/jnen/nlaa003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlaa003</ArticleId><ArticleId IdType="pubmed">32142134</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyzack GE, et al. Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis. Brain. 2019;142:2572&#x2013;2580. doi: 10.1093/brain/awz217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz217</ArticleId><ArticleId IdType="pmc">PMC6735815</ArticleId><ArticleId IdType="pubmed">31368485</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, et al. ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules. Hum. Mol. Genet. 2013;22:2676&#x2013;2688. doi: 10.1093/hmg/ddt117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt117</ArticleId><ArticleId IdType="pmc">PMC3674807</ArticleId><ArticleId IdType="pubmed">23474818</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito D, Seki M, Tsunoda Y, Uchiyama H, Suzuki N. Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS. Ann. Neurol. 2011;69:152&#x2013;162. doi: 10.1002/ana.22246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22246</ArticleId><ArticleId IdType="pubmed">21280085</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg MA, et al. Mutant FUS induces endoplasmic reticulum stress in amyotrophic lateral sclerosis and interacts with protein disulfide-isomerase. Neurobiol. Aging. 2012;33:2855&#x2013;2868. doi: 10.1016/j.neurobiolaging.2012.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.02.009</ArticleId><ArticleId IdType="pubmed">22459602</ArticleId></ArticleIdList></Reference><Reference><Citation>Soo KY, et al. Rab1-dependent ER&#x2013;Golgi transport dysfunction is a common pathogenic mechanism in SOD1, TDP-43 and FUS-associated ALS. Acta Neuropathol. 2015;130:679&#x2013;697. doi: 10.1007/s00401-015-1468-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1468-2</ArticleId><ArticleId IdType="pubmed">26298469</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg MA, et al. Ataxin-2 interacts with FUS and intermediate-length polyglutamine expansions enhance FUS-related pathology in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2013;22:717&#x2013;728. doi: 10.1093/hmg/dds479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds479</ArticleId><ArticleId IdType="pubmed">23172909</ArticleId></ArticleIdList></Reference><Reference><Citation>Parakh S, Atkin JD. Novel roles for protein disulphide isomerase in disease states: A double edged sword? Front. Cell Dev. Biol. 2015;3:30. doi: 10.3389/fcell.2015.00030.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2015.00030</ArticleId><ArticleId IdType="pmc">PMC4439577</ArticleId><ArticleId IdType="pubmed">26052512</ArticleId></ArticleIdList></Reference><Reference><Citation>Parakh S, et al. The redox activity of protein disulfide isomerase inhibits ALS phenotypes in cellular and zebrafish models. iScience. 2020;23:101097. doi: 10.1016/j.isci.2020.101097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101097</ArticleId><ArticleId IdType="pmc">PMC7240177</ArticleId><ArticleId IdType="pubmed">32446203</ArticleId></ArticleIdList></Reference><Reference><Citation>Parakh S, et al. ERp57 is protective against mutant SOD1-induced cellular pathology in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2018;27:1311&#x2013;1331. doi: 10.1093/hmg/ddy041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy041</ArticleId><ArticleId IdType="pubmed">29409023</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AK, et al. Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis. Brain. 2010;133:105&#x2013;116. doi: 10.1093/brain/awp267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp267</ArticleId><ArticleId IdType="pubmed">19903735</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Perez P, et al. Identification of rare protein disulfide isomerase gene variants in amyotrophic lateral sclerosis patients. Gene. 2015;566:158&#x2013;165. doi: 10.1016/j.gene.2015.04.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2015.04.035</ArticleId><ArticleId IdType="pmc">PMC5553116</ArticleId><ArticleId IdType="pubmed">25913742</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozas P, et al. Protein disulfide isomerase ERp57 protects early muscle denervation in experimental ALS. Acta Neuropathol. Commun. 2021;9(1):21. doi: 10.1186/s40478-020-01116-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01116-z</ArticleId><ArticleId IdType="pmc">PMC7863244</ArticleId><ArticleId IdType="pubmed">33541434</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrawell NE, et al. Distinct partitioning of ALS associated TDP-43, FUS and SOD1 mutants into cellular inclusions. Sci. Rep. 2015;5:13416. doi: 10.1038/srep13416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep13416</ArticleId><ArticleId IdType="pmc">PMC4544019</ArticleId><ArticleId IdType="pubmed">26293199</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou CC, Zhang Y. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat. Neurosci. 2018;21:228&#x2013;239. doi: 10.1038/s41593-017-0047-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0047-3</ArticleId><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature. 2015;525:56&#x2013;61. doi: 10.1038/nature14973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14973</ArticleId><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagstaff KM, Rawlinson SM, Hearps AC, Jans DA. An AlphaScreen&#xae;-based assay for high-throughput screening for specific inhibitors of nuclear import. J. Biomol. Screen. 2011;16:192&#x2013;200. doi: 10.1177/1087057110390360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1087057110390360</ArticleId><ArticleId IdType="pubmed">21297106</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D, et al. ALS-associated fused in sarcoma (FUS) mutations disrupt transportin-mediated nuclear import. EMBO J. 2010;29:2841&#x2013;2857. doi: 10.1038/emboj.2010.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.143</ArticleId><ArticleId IdType="pmc">PMC2924641</ArticleId><ArticleId IdType="pubmed">20606625</ArticleId></ArticleIdList></Reference><Reference><Citation>Presley JF, et al. ER-to-Golgi transport visualized in living cells. Nature. 1997;389:81&#x2013;85. doi: 10.1038/38001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/38001</ArticleId><ArticleId IdType="pubmed">9288971</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkin JD, et al. Mutant SOD 1 inhibits ER-Golgi transport in amyotrophic lateral sclerosis. J. Neurochem. 2014;129:190&#x2013;204. doi: 10.1111/jnc.12493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12493</ArticleId><ArticleId IdType="pubmed">24134191</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewitt C, et al. Novel FUS/TLS mutations and pathology in familial and sporadic amyotrophic lateral sclerosis. Arch. Neurol. 2010;67:455&#x2013;461. doi: 10.1001/archneurol.2010.52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2010.52</ArticleId><ArticleId IdType="pubmed">20385912</ArticleId></ArticleIdList></Reference><Reference><Citation>Woehlbier U, et al. ALS-linked protein disulfide isomerase variants cause motor dysfunction. EMBO J. 2016;35:845&#x2013;865. doi: 10.15252/embj.201592224.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201592224</ArticleId><ArticleId IdType="pmc">PMC4972141</ArticleId><ArticleId IdType="pubmed">26869642</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo V, et al. Functional role of the disulfide isomerase ERp57 in axonal regeneration. PLoS ONE. 2015;10:e0136620&#x2013;e0136620. doi: 10.1371/journal.pone.0136620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0136620</ArticleId><ArticleId IdType="pmc">PMC4567344</ArticleId><ArticleId IdType="pubmed">26361352</ArticleId></ArticleIdList></Reference><Reference><Citation>Ederle H, Dormann D. TDP-43 and FUS en route from the nucleus to the cytoplasm. FEBS Lett. 2017;591:1489&#x2013;1507. doi: 10.1002/1873-3468.12646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.12646</ArticleId><ArticleId IdType="pubmed">28380257</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovi&#x10d;i&#x107; A, et al. Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat. Neurosci. 2015;18:1226&#x2013;1229. doi: 10.1038/nn.4085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4085</ArticleId><ArticleId IdType="pmc">PMC4552077</ArticleId><ArticleId IdType="pubmed">26308983</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015;525:129&#x2013;133. doi: 10.1038/nature14974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14974</ArticleId><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Turano C, Coppari S, Altieri F, Ferraro A. Proteins of the PDI family: Unpredicted non-ER locations and functions. J. Cell. Physiol. 2002;193:154&#x2013;163. doi: 10.1002/jcp.10172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.10172</ArticleId><ArticleId IdType="pubmed">12384992</ArticleId></ArticleIdList></Reference><Reference><Citation>VanderWaal RP, Spitz DR, Griffith CL, Higashikubo R, Roti Roti JL. Evidence that protein disulfide isomerase (PDI) is involved in DNA-nuclear matrix anchoring. J. Cell. Biochem. 2002;85:689&#x2013;702. doi: 10.1002/jcb.10169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.10169</ArticleId><ArticleId IdType="pubmed">11968009</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali Khan H, Mutus B. Protein disulfide isomerase a multifunctional protein with multiple physiological roles. Front. Chem. 2014;2:70. doi: 10.3389/fchem.2014.00070.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fchem.2014.00070</ArticleId><ArticleId IdType="pmc">PMC4144422</ArticleId><ArticleId IdType="pubmed">25207270</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang YS, Harel NY, Strittmatter SM. Reticulon-4A (Nogo-A) redistributes protein disulfide isomerase to protect mice from SOD1-dependent amyotrophic lateral sclerosis. J. Neurosci. 2009;29:13850&#x2013;13859. doi: 10.1523/JNEUROSCI.2312-09.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2312-09.2009</ArticleId><ArticleId IdType="pmc">PMC2797811</ArticleId><ArticleId IdType="pubmed">19889996</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernardoni P, et al. Reticulon1-C modulates protein disulphide isomerase function. Cell Death Dis. 2013;4:e581&#x2013;e581. doi: 10.1038/cddis.2013.113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2013.113</ArticleId><ArticleId IdType="pmc">PMC3641336</ArticleId><ArticleId IdType="pubmed">23559015</ArticleId></ArticleIdList></Reference><Reference><Citation>Igbaria A, et al. Chaperone-mediated reflux of secretory proteins to the cytosol during endoplasmic reticulum stress. Proc. Natl. Acad. Sci. 2019;116:11291. doi: 10.1073/pnas.1904516116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1904516116</ArticleId><ArticleId IdType="pmc">PMC6561268</ArticleId><ArticleId IdType="pubmed">31101715</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundaramoorthy V, Sultana JM, Atkin JD. Golgi fragmentation in amyotrophic lateral sclerosis, an overview of possible triggers and consequences. Front. Neurosci. 2015;9:400&#x2013;400. doi: 10.3389/fnins.2015.00400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2015.00400</ArticleId><ArticleId IdType="pmc">PMC4621950</ArticleId><ArticleId IdType="pubmed">26578862</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagomi S, et al. A Golgi fragmentation pathway in neurodegeneration. Neurobiol. Dis. 2008;29:221&#x2013;231. doi: 10.1016/j.nbd.2007.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2007.08.015</ArticleId><ArticleId IdType="pmc">PMC2261378</ArticleId><ArticleId IdType="pubmed">17964175</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippincott-Schwartz J, Roberts TH, Hirschberg K. Secretory protein trafficking and organelle dynamics in living cells. Annu. Rev. Cell Dev. Biol. 2000;16:557&#x2013;589. doi: 10.1146/annurev.cellbio.16.1.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.cellbio.16.1.557</ArticleId><ArticleId IdType="pmc">PMC4781643</ArticleId><ArticleId IdType="pubmed">11031247</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezzacasa A, Helenius A. The transitional ER defines a boundary for quality control in the secretion of tsO45 VSV glycoprotein. Traffic. 2002;3:833&#x2013;849. doi: 10.1034/j.1600-0854.2002.31108.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0854.2002.31108.x</ArticleId><ArticleId IdType="pubmed">12383349</ArticleId></ArticleIdList></Reference><Reference><Citation>Aridor M, Weissman J, Bannykh S, Nuoffer C, Balch WE. Cargo selection by the COPII budding machinery during export from the ER. J. Cell Biol. 1998;141:61&#x2013;70. doi: 10.1083/jcb.141.1.61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.141.1.61</ArticleId><ArticleId IdType="pmc">PMC2132735</ArticleId><ArticleId IdType="pubmed">9531548</ArticleId></ArticleIdList></Reference><Reference><Citation>Fromme JC. Membrane trafficking: Licensing a cargo receptor for ER export. Curr. Biol. 2015;25:R67&#x2013;r68. doi: 10.1016/j.cub.2014.11.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2014.11.051</ArticleId><ArticleId IdType="pubmed">25602305</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen TJ, Hwang AW, Unger T, Trojanowski JQ, Lee VMY. Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking. EMBO J. 2012;31:1241&#x2013;1252. doi: 10.1038/emboj.2011.471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2011.471</ArticleId><ArticleId IdType="pmc">PMC3297986</ArticleId><ArticleId IdType="pubmed">22193716</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogawa M, et al. Cysteine residues in Cu, Zn-superoxide dismutase are essential to toxicity in Caenorhabditis elegans model of amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2015;463:1196&#x2013;1202. doi: 10.1016/j.bbrc.2015.06.084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2015.06.084</ArticleId><ArticleId IdType="pubmed">26086102</ArticleId></ArticleIdList></Reference><Reference><Citation>Iko Y, et al. Domain architectures and characterization of an RNA-binding protein, TLS. J. Biol. Chem. 2004;279:44834&#x2013;44840. doi: 10.1074/jbc.M408552200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M408552200</ArticleId><ArticleId IdType="pubmed">15299008</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitler AD, Shorter J. RNA-binding proteins with prion-like domains in ALS and FTLD-U. Prion. 2011;5:179&#x2013;187. doi: 10.4161/pri.5.3.17230.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/pri.5.3.17230</ArticleId><ArticleId IdType="pmc">PMC3226045</ArticleId><ArticleId IdType="pubmed">21847013</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts JC, et al. Interactome analyses identify ties of PrP and its mammalian paralogs to oligomannosidic N-glycans and endoplasmic reticulum-derived chaperones. PLoS Pathog. 2009;5:e1000608. doi: 10.1371/journal.ppat.1000608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000608</ArticleId><ArticleId IdType="pmc">PMC2749441</ArticleId><ArticleId IdType="pubmed">19798432</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessop CE, Watkins RH, Simmons JJ, Tasab M, Bulleid NJ. Protein disulphide isomerase family members show distinct substrate specificity: P5 is targeted to BiP client proteins. J. Cell Sci. 2009;122:4287&#x2013;4295. doi: 10.1242/jcs.059154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.059154</ArticleId><ArticleId IdType="pmc">PMC2779130</ArticleId><ArticleId IdType="pubmed">19887585</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess A, et al. Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance. Proc. Natl. Acad. Sci. USA. 2010;107:12564&#x2013;12569. doi: 10.1073/pnas.0914191107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0914191107</ArticleId><ArticleId IdType="pmc">PMC2906566</ArticleId><ArticleId IdType="pubmed">20538976</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolte S, Cordeli&#xe8;res FP. A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc. 2006;224:213&#x2013;232. doi: 10.1111/j.1365-2818.2006.01706.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2818.2006.01706.x</ArticleId><ArticleId IdType="pubmed">17210054</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>